s6y
Company name or ticker
Search
Neumora Therapeutics, Inc.
DEF 14A
Definitive proxy statements
Filed
Thursday, April 25, 2024
Period
Jun 13, 2024
Accession number
0000950170-24-048287
Documents
Definitive proxy statements
DEF 14A
On sec.gov
Filing index
All files
Complete submission text
SGML header